Compagnie Lombard Odier S Cm A Global Blood Therapeutics, Inc. Transaction History

Compagnie Lombard Odier S Cm A

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 11, 2018	SELL	$39.6 - $65.9 $1.2 Million - $1.99 Million	-30,250 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$29.7 - $45.7 $1.89 Million - $2.91 Million	-63,588 Reduced 67.76%	30,250 $1.19 Million
Q3 2017 Nov 14, 2017	SELL	$25.1 - $31.05 $127,708 - $157,982	-5,088 Reduced 5.14%	93,838 $2.91 Million
Q2 2017 Aug 14, 2017	BUY	N/A	98,926	98,926 $2.71 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.